RecruitingPhase 2NCT07189208
Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil
Studying Congenital syphilis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Los Angeles
- Intervention
- Benzathine penicillin 2.4 million units(drug)
- Enrollment
- 500 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2025 – 2030
Study locations (4)
- Centro de Referencia e Atenção Especializada a Saúde da Mulher (CRAESM), Duque de Caxias, Rio de Janeiro, Brazil
- Policlínica Hospital Municipal Duque de Caxias, Duque de Caxias, Rio de Janeiro, Brazil
- Unidade Básica de Saúde José de Freitas, Duque de Caxias, Rio de Janeiro, Brazil
- Hospital Federal dos Servidores do Estado, Rio de Janeiro, Rio de Janeiro, Brazil
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07189208 on ClinicalTrials.govOther trials for Congenital syphilis
Additional recruiting or active studies for the same condition.